Cocrystal Pharma, Inc. Common Stock COCP
Key Stats
- Today's Range
- $1.10 – $1.19
- 50-Day Range
- $0.76 – $1.23
- 52-Week Range
- $0.76 – $2.67
- Volume
- 46K shs
- Average Volume
- 67K shs
- Market Cap
- $22.15 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.08%
- Days to Cover
- 1.00
About Cocrystal Pharma, Inc. Common Stock
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.
Related Stocks
Compare head-to-head: COCP vs LLY·COCP vs JNJ·COCP vs ABBV·COCP vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.